Janux Therapeutics Cash Flow Statement (2020-2026) | JANX

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-6.21M-83.44M-13.42M-48.43M-54.68M-54.41M-16.41M-54.89M-54.12M-26.64M-11.76M-268.52M-292.84M-341.55M-20.22M-154.68M-132.53M-131.16M-31.95M-52.86M
Depreciation and Depletion (Quarter)
0.01M0.03M0.06M0.08M0.11M0.25M0.40M0.45M0.47M0.50M0.53M0.53M0.51M0.51M0.51M0.52M0.54M0.50M0.47M0.47M
Share-based Compensation (Quarter)
1.28M2.57M2.94M3.96M4.44M4.60M4.21M5.47M5.50M4.55M4.48M5.62M5.76M15.39M6.25M10.70M75.90M61.20M9.52M28.50M
Cash from Operations (Quarter)
-6.20M-5.85M-10.48M-11.52M-6.07M-13.41M-11.91M-13.91M-15.05M-11.71M-9.90M-14.84M-10.02M-2.23M-16.73M-17.02M-23.81M-12.86M-28.54M-12.34M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.04M0.08M0.06M0.02M0.10M0.77M1.29M1.68M1.84M2.11M2.06M1.79M2.97M2.90M2.93M4.22M5.21M4.62M3.52M2.62M
Depreciation & Amortization (CF) (Quarter)
0.01M0.03M0.06M0.08M0.11M0.25M0.40M0.45M0.47M0.50M0.53M0.53M0.51M0.51M0.51M0.52M0.54M0.50M0.47M0.47M
Change in Working Capital
Change in Receivables (Quarter)
-0.38M0.50M-0.50M0.75M-0.75M0.52M6.98M35.00M
Change in Account Payables (Quarter)
-0.31M2.58M-0.48M-0.74M0.86M-0.63M0.22M-0.11M-0.17M0.23M0.33M-0.46M-0.69M1.18M1.56M-1.64M1.11M-0.17M1.67M-1.61M
Change in Accured Expenses (Quarter)
0.94M0.41M1.92M1.16M-0.89M2.89M1.00M-0.56M1.44M-1.99M0.43M-1.57M3.06M4.57M-1.63M1.73M2.89M6.18M-4.52M-2.03M
Investing Activities
Capital Expenditures (Quarter)
0.23M-0.09M0.25M0.40M1.47M-0.91M0.31M0.28M0.76M0.29M0.52M0.20M0.10M-0.25M0.33M-0.09M0.94M0.09M-1.21M0.27M
Change in Acquisitions & Divestments (Quarter)
22.14M112.00M77.10M78.75M116.75M86.50M63.25M95.00M75.00M44.75M65.00M44.75M45.16M58.00M31.27M94.72M126.37M152.93M121.31M
Cash from Investing Activities (Quarter)
-142.60M-205.54M7.33M31.07M9.04M19.76M-1.60M-8.74M17.87M-61.45M11.12M-113.74M-190.88M12.67M33.93M-340.39M1.56M8.31M29.54M8.29M
Financing Activities
Other financing activities (Quarter)
-0.84M1.58M1.66M0.90M3.54M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
68.83M-69.10M
Change in Capital Stock
Shares Issued (Quarter)
5.17M5.55M5.65M4.98M7.55M7.59M7.35M8.89M9.08M5.41M7.99M5.60M9.66M9.59M8.87M10.00M10.21M9.95M9.55M10.39M
Misc.
Cash from Financing Activities (Quarter)
329.66M-0.84M0.16M0.00M0.31M0.19M1.58M0.53M56.61M0.83M322.17M2.77M1.65M386.65M0.55M0.95M0.49M2.94M3.54M
Change in Cash (Quarter)
180.86M-212.24M-2.99M19.55M3.27M6.35M-13.33M-21.07M3.35M-16.55M2.05M193.60M-198.14M12.09M403.85M-356.86M-21.30M-4.06M3.94M-0.51M
Free Cash Flow (Quarter)
-6.44M-5.76M-10.73M-11.92M-7.55M-12.50M-12.23M-14.20M-15.81M-12.00M-10.42M-15.03M-10.12M-1.98M-17.06M-16.93M-24.75M-12.95M-27.33M-12.61M
Net Cash Flow (Quarter)
180.86M-212.24M-2.99M19.55M3.27M6.35M-13.33M-21.07M3.35M-16.55M2.05M193.60M-198.14M12.09M403.85M-356.86M-21.30M-4.06M3.94M-0.51M